Vimarsana
Biggest News Aggregation in the World

Page 5 - Bgne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bgne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bgne Today - Breaking & Trending Today

BeiGene Trial of Lung-Cancer Treatment Reaches Primary Endpoints - Vimarsana News

BeiGene Trial of Lung-Cancer Treatment Reaches Primary Endpoints

By Ben Glickman BeiGene's trial of the use of tislelizumab to treat resectable non-small cell lung cancer, when combined with chemotherapy, reached its dual...

BeiGene Brukinsa Recommended for Approval From European Medicines Agency Committee - Vimarsana News

BeiGene Brukinsa Recommended for Approval From European Medicines Agency Committee

By Denny Jacob BeiGene's brukinsa received a positive opinion recommending its approval from an European Medicines Agency committee. The biotechnology...

BeiGene, Ltd. (NASDAQ:BGNE) Receives $273.46 Average Target Price from Analysts - Vimarsana News

BeiGene, Ltd. (NASDAQ:BGNE) Receives $273.46 Average Target Price from Analysts

BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year target price among […]

BeiGene, Ltd. (NASDAQ:BGNE) Given Consensus Recommendation of "Moderate Buy" by Analysts - Vimarsana News

BeiGene, Ltd. (NASDAQ:BGNE) Given Consensus Recommendation of "Moderate Buy" by Analysts

BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12 month target price among brokerages […]

BeiGene (NASDAQ:BGNE) Lowered to "Sell" at StockNews.com - Vimarsana News

BeiGene (NASDAQ:BGNE) Lowered to "Sell" at StockNews.com

BeiGene (NASDAQ:BGNE – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Monday. BGNE has been the subject of several other reports. 22nd Century Group reaffirmed a “downgrade” rating on shares of BeiGene in a research note on Friday, […]